BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24157417)

  • 21. Genome-wide association between DNA methylation and alternative splicing in an invertebrate.
    Flores K; Wolschin F; Corneveaux JJ; Allen AN; Huentelman MJ; Amdam GV
    BMC Genomics; 2012 Sep; 13():480. PubMed ID: 22978521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis and modeling of DNA methylation susceptibility in 30 breast cancer cell lines by using CpG flanking sequences.
    An J; Kim K; Rhee SM; Chae H; Nephew KP; Kim S
    J Bioinform Comput Biol; 2013 Jun; 11(3):1341003. PubMed ID: 23796180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploiting CpG hypermutability to identify phenotypically significant variation within human protein-coding genes.
    Ying H; Huttley G
    Genome Biol Evol; 2011; 3():938-49. PubMed ID: 21398426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High resolution methylome map of rat indicates role of intragenic DNA methylation in identification of coding region.
    Sati S; Tanwar VS; Kumar KA; Patowary A; Jain V; Ghosh S; Ahmad S; Singh M; Reddy SU; Chandak GR; Raghunath M; Sivasubbu S; Chakraborty K; Scaria V; Sengupta S
    PLoS One; 2012; 7(2):e31621. PubMed ID: 22355382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periodicity of eight nucleotides in purine distribution around human genomic CpG dinucleotides.
    Clay O; Schaffner W; Matsuo K
    Somat Cell Mol Genet; 1995 Mar; 21(2):91-8. PubMed ID: 7570188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypermutable non-synonymous sites are under stronger negative selection.
    Schmidt S; Gerasimova A; Kondrashov FA; Adzhubei IA; Adzuhbei IA; Kondrashov AS; Sunyaev S
    PLoS Genet; 2008 Nov; 4(11):e1000281. PubMed ID: 19043566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analyses of DNA methylation and sequence evolution using Nasonia genomes.
    Park J; Peng Z; Zeng J; Elango N; Park T; Wheeler D; Werren JH; Yi SV
    Mol Biol Evol; 2011 Dec; 28(12):3345-54. PubMed ID: 21693438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human non-CpG methylation patterns display both tissue-specific and inter-individual differences suggestive of underlying function.
    Titcombe P; Murray R; Hewitt M; Antoun E; Cooper C; Inskip HM; Holbrook JD; Godfrey KM; Lillycrop K; Hanson M; Barton SJ
    Epigenetics; 2022 Jun; 17(6):653-664. PubMed ID: 34461806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosine Methylation Affects the Mutability of Neighboring Nucleotides in Germline and Soma.
    Kusmartsev V; Drożdż M; Schuster-Böckler B; Warnecke T
    Genetics; 2020 Apr; 214(4):809-823. PubMed ID: 32079595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5' region on the active and inactive X chromosomes: correlation with binding sites for transcription factors.
    Hornstra IK; Yang TP
    Mol Cell Biol; 1994 Feb; 14(2):1419-30. PubMed ID: 8289817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation induced deaminase mutational signature overlaps with CpG methylation sites in follicular lymphoma and other cancers.
    Rogozin IB; Lada AG; Goncearenco A; Green MR; De S; Nudelman G; Panchenko AR; Koonin EV; Pavlov YI
    Sci Rep; 2016 Dec; 6():38133. PubMed ID: 27924834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolutionary conservation of DNA methylation in CpG sites within ultraconserved noncoding elements.
    Colwell M; Drown M; Showel K; Drown C; Palowski A; Faulk C
    Epigenetics; 2018; 13(1):49-60. PubMed ID: 29372669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleosome deposition and DNA methylation at coding region boundaries.
    Choi JK; Bae JB; Lyu J; Kim TY; Kim YJ
    Genome Biol; 2009; 10(9):R89. PubMed ID: 19723310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleosome dynamics and maintenance of epigenetic states of CpG islands.
    Sneppen K; Dodd IB
    Phys Rev E; 2016 Jun; 93(6):062417. PubMed ID: 27415308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene.
    Allaman-Pillet N; Djemaï A; Bonny C; Schorderet DF
    Gene Expr; 1998; 7(2):61-73. PubMed ID: 9699479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the assignment of ancestral CpG state on the estimation of nucleotide substitution rates in mammals.
    Gaffney DJ; Keightley PD
    BMC Evol Biol; 2008 Sep; 8():265. PubMed ID: 18826599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region.
    Vu TH; Li T; Nguyen D; Nguyen BT; Yao XM; Hu JF; Hoffman AR
    Genomics; 2000 Mar; 64(2):132-43. PubMed ID: 10729220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution rate variation at human CpG sites correlates with non-CpG divergence, methylation level and GC content.
    Mugal CF; Ellegren H
    Genome Biol; 2011 Jun; 12(6):R58. PubMed ID: 21696599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unveiling the methylation status of CpG dinucleotides in the substituted segment of the human p53 knock-in (Hupki) mouse genome.
    Kim SI; Hollstein M; Pfeifer GP; Besaratinia A
    Mol Carcinog; 2010 Dec; 49(12):999-1006. PubMed ID: 20945503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.